Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis: Results from a Prospective Pilot Study.

Travis E GrotzJennifer A YonkusCornelius A ThielsSusanne G WarnerRobert R McWilliamsAmit MahipalTanios S Bekaii-SaabSean P ClearyMichael L KendrickMark J Truty

Published in: Annals of surgical oncology (2022)

Cytoreduction and HIPEC for selected patients with low-volume PM from PDAC is safe and feasible with favorable short-term outcomes. A phase II trial (NCT04858009) is now enrolling to further assess this multimodality approach in select patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
particulate matter
clinical trial
open label
heavy metals
polycyclic aromatic hydrocarbons
patient reported